The integrin b1 subunit and its downstream molecule focal adhesion kinase have been identified as critical molecules for the inhibition of postinfarction cardiac remodeling, ischemic cardiomyopathy, and heart failure. However, as a component of the integrin pathway, it is still unclear whether Dock180 (dedicator of cytokinesis 1) protein is expressed in the noninfarcted myocardium of the peri-infarct zones. In this study, experimental myocardial infarction (MI) and sham-operation (sham) models were established in Sprague Dawley rats and the expression of Dock180 protein in the myocardium of the sham group and in the noninfarcted myocardium of the peri-infarct zones of the MI group was detected by Western blot technique. The Dock180 protein expression in the myocardium was as follows: postsham 24-hour group, 0.10 AE 0.04 (n ¼ 8); post-MI 24-hour group, 0.13 AE 0.03 (n ¼ 8); postsham 12-week group, 0.11 AE 0.05 (n ¼ 8); and post-MI 12-week group 0.17 AE 0.04 (n ¼ 8). The Dock180 protein expression in the myocardium in the post-MI 12-week group was significantly higher than that in the postsham 12-week group ( p ¼ 0.019), in the postsham 24-hour group ( p ¼ 0.004), and in the post-MI 24-hour group ( p ¼ 0.040). We conclude that Dock180 protein is expressed in the myocardium in rats. Furthermore, its expression is significantly increased in the noninfarcted myocardium of the periinfarct zones.
Introduction
Recently, integrin b1 subunit and its downstream molecule focal adhesion kinase (FAK) have been discovered to exist in the cardiomyocytes and play critical roles in the inhibition of postinfarction cardiac remodeling, ischemic cardiomyopathy, and heart failure through their attenuation of apoptosis and survival inhibition of cardiomyocytes in the noninfarcted myocardium of the peri-infarct zones.
1,2 However, as a component of the integrin pathway, 3 it is still unclear whether Dock180 (dedicator of cytokinesis 1) protein expresses in the noninfarcted myocardium of the peri-infarct zones.
In this study, Dock180 protein expression was confirmed to exist, and furthermore, its expression was significantly increased in the noninfarcted myocardium of the peri-infarct zones in rat experimental myocardial infarction (MI) model.
Methods

MI model and experimental protocol
Experimental MI and sham-operation (sham) models were established in 50 Sprague Dawley adult male rats with body weight (BW) 207.3 AE 22.55 g (supplied by the Laboratory Animal Center of the Chongqing Medical University, Chongqing, China). The models were established in accordance with the EC Directive 86/609/ECC for animal experiments. 4 The rats were anesthetized (intraperitoneal administration of 10% chloral hydrate sodium; 0.3 mL/100 g), endotracheally intubated, and mechanically ventilated with a rodent ventilator. The heart was exposed by a left thoracotomy, and the proximal left anterior descending coronary artery was permanently ligated with a 6e0 silk suture. The successful coronary occlusion was confirmed by visual cyanosis of the anterior wall of the left ventricle (LV) and by the elevation of the ST segment on electrocardiogram. The chest was then closed in three layers (ribs, muscles, and skin). The rats were allowed to recover under care. Sham operations were performed using the same procedure, but without the ligation of the coronary artery. The surviving rats after the operation were divided into the postsham 24-hour group (n ¼ 8), the post-MI 24-hour group (n ¼ 8), the postsham 12-week group (n ¼ 8), and the post-MI 12-week group (n ¼ 8).
All rat experiments were approved by the local institutional animal research committee.
Echocardiographic measurements
Transthoracic Doppler echocardiographic studies were performed at each time point with a commercially available echocardiographic system (Vivid 7, General Electric Co., Fairfield, CT, USA), which was equipped with a 13-MHz sector scan transducer. The rats were anesthetized as before, and transthoracic M-mode echocardiograms guided by twodimensional short-axis images of the LV were obtained at the level of the papillary muscles. The LV end-diastolic diameter (LVEDD), LV ejection fraction (LVEF), and heart rate were measured from the M-mode tracings. 4 For each measurement, data from at least three consecutive cardiac cycles were averaged. The observer was blinded to the experimental group assignment.
Histology
At each time point, BW was measured again. All rats were then killed after the echocardiography. The hearts were rapidly excised, and the atria and vasculature were dissected out. The LV was separated from the right ventricle and weighted. The LV/BW (mg/g) ratio was calculated. The infarcted and noninfarcted zones in LV were outlined by visual inspections. The infarcted myocardium in LV was immersed in a fixative solution, dehydrated, embedded in paraffin, and then used for calculating the infarction size (IS). In brief, 5-mm thick histological slices were obtained and stained with hematoxylin and eosin (H&E) stain. Endocardial and epicardial circumferences of the infarcted tissue and the LV were determined using the image analysis software (Image-Pro Plus 6.0). IS was calculated as follows: (endocardial þ epicardial circumference of the infarcted tissue)/(endocardial þ epicardial circumference of the LV). One part of the noninfarcted myocardium in LV was immersed in the fixative solution, dehydrated, embedded in paraffin, and then used for H&E and picrosirius red staining. After staining the sections with picrosirius red, the collagen volume fraction (CVF) is measured as follows: two sections per animal and 20 fields per section were scanned and computerized with an image analyzer (Image pro plus 6.0) on the basis of the red staining of the collagen. The CVF was calculated as the sum of all collagen tissue areas divided by the total areas of the images. The remaining noninfarcted myocardium in LV was frozen in liquid nitrogen, and stored in the À80 C freezer in order to be used for Western blot analysis.
Western blot analysis of Dock180 protein
Myocardium tissue homogenates and lysates were prepared with lysis buffer containing protease inhibitors. The concentration of protein was measured using bicinchoninic acid protein assay kit (Beyotime Biotechnology Co., Ltd., Shanghai, China) and standardized (aliquots of supernatants containing equal amounts of proteins). Equal amount (50 mg) of protein was separated by 10% sodium dodecyl sulfateepolyacrylamide gel electrophoresis, and electrophoretically transferred to a polyvinylidene difluoride membrane (Millipore Co., Bedford, MA, USA). Nonspecific sites were blocked by incubating the membranes in a blocking buffer (3% bovine serum albumin in Tween 20-tris-buffered saline) for 2 hours at room temperature. C, and then with horseradish peroxidaseeconjugated antimouse or antirabbit second antibody (immunoglobulin G, 1:1500; Boster Biosynthesis Biotechnology Co., Ltd., Wuhan, China) for 1 hour at room temperature. The immunoreactive bands were visualized by incubating with diaminobenzidine in BeyoECL Plus (Beyotime Biotechnology Co., Ltd., Shanghai, China) and photographed by ChemiDoc XRS detection system (Bio-Rad, Hercules, CA, USA). The absorbance of the bands was analyzed using image analysis software (Quantity One 4.4.0). The density of Dock180 in relation to b-actin was expressed as Dock180/b-actin, which represents the relative expression level of Dock180 protein.
Statistical analysis
All of the experiments were repeated at least three times. Data are presented as mean AE standard deviation. All analyses were performed using the SPSS version 17.0 statistical software. The statistical significance among groups was evaluated by one-way analysis of variance, followed by a two-side Tukey test for multiple comparisons (in case of significance). A value of p < 0.05 was considered to be statistically significant. In all the cases, p < 0.05 (Fig. 3) .
Discussion
In this study, we have demonstrated that Dock180 protein was expressed in the LV myocardium of normal adult rats.
Furthermore, its expression was increased in the noninfarcted myocardium of the peri-infarct zones with time.
The integrin pathway links extracellular matrix substances to the actin cytoskeleton in cardiomyocytes, senses mechanical stretch, and translates it into intracellular biochemical signaling. 3 Knockout of the integrin b1 subunit or its downstream molecule (FAK) exclusively in the cardiomyocytes could accelerate the postinfarction cardiac remodeling, ischemic cardiomyopathy, and heart failure in the knockout mice because of increased apoptosis and survival inhibition in the cardiomyocytes of the knockout mice.
1,2 However, overexpression of integrin-linked kinase could improve the postinfarction cardiac remodeling, ischemic cardiomyopathy, and heart failure via its antiapoptosis and pro-survival effects on the cardiomyocytes. 5 The above studies provided evidence that the integrin pathway could play crucial cardioprotective roles in the alleviation of postinfarction cardiac remodeling, ischemic cardiomyopathy, and heart failure through its antiapoptosis and pro-survival effects on the cardiomyocytes, which could be mediated most possibly by activation of its downstream pro-survival signaling molecules such as ERK 6e8 and PI3K/AKT/mTOR/p70S6K. 7e10 A novel potential therapy targeting the integrin pathway could be developed to relieve the postinfarction cardiac remodeling, fibrosis, ischemic cardiomyopathy, and heart failure. 11 Combined with the facts that Dock180 protein is one of the integrin pathway components, 3 we wondered whether Dock180 protein exhibited expression in the normal myocardium and in the noninfarcted myocardium of the peri-infarct zones. Dock180 protein is a guanine nucleotide exchange factor family member in the integrin pathway. Dock180 protein binds with N-terminal SH3 domain of its upstream adaptor Crk following stimulation by signals through integrin, and subsequently activates GTPases such as Rac1 and Rho. 12, 13 Dock180 protein regulates apoptosis and cell proliferation in noncardiomyocytes. 14 However, little information is available about its expression in the normal myocardium and in the noninfarcted myocardium of the peri-infarct zones.
In this study, we provided evidence for the first time that the Dock180 protein expresses in the adult rat myocardium. Moreover, the significantly increased expression of Dock180 protein was observed in the noninfarcted myocardium of the peri-infarct zones. In the same way, three other study groups have found that the expression of integrin a1, a5, b1, and b3 subunits was increased in the noninfarcted myocardium of the peri-infarct zones. 1, 15, 16 However, the underlying mechanisms of the association of Dock180 protein with the postinfarction cardiac remodeling, fibrosis, ischemic cardiomyopathy, and heart failure are still incompletely clear. The roles of Dock180 protein in the apoptosis and cell survival of cardiomyocytes remain to be defined. In conclusion, Dock180 protein was significantly increased in the noninfarcted myocardium of the peri-infarct zones. 
